Study reveals that plant-based meat alternatives (PBMAs) may offer cardioprotective benefits compared to animal meat, but their classification as ultra-processed foods warrants further long-term research.
FDA accepts Sanofi’s Sarclisa sBLA for priority review
In a Phase III trial, Sanofi’s Sarclisa regimen offered statistically significant PFS improvement in NDMM patients. Credit: Sergiy Palamarchuk/ Shutterstock.com. The US Food and Drug
May 28, 2024